Trial intelligence / Profile preview

Misoprostol versus chewing gum for postoperative bowel motility after cesarean delivery

IRCT20141209020258N74Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of misoprostol in postoperative ileus (POI) (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Effect on intestinal motility after cesarean section. Started Sep 2016; status: completed.

02

Drugs

misoprostol
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on IRCT20141209020258N74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call